Study on treatment strategy for ventriculitis associated with ventriculoperitoneal shunt for hydrocephalus

OBJECTIVE: To study the treatment strategy for ventriculitis associated with ventriculo peritoneal shunt for hydrocephalus

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 17(2005), 9 vom: 08. Sept., Seite 558-60
1. Verfasser: Li, Xiao-yong (VerfasserIn)
Weitere Verfasser: Wang, Zhong-cheng, Li, Yin-Ping, Ma, Zhen-yu, Yang, Jun, Cao, Er-cheng
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2005
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:English Abstract Journal Article Anti-Bacterial Agents Vancomycin 6Q205EH1VU
LEADER 01000caa a22002652 4500
001 NLM157631877
003 DE-627
005 20250206162950.0
007 tu
008 231223s2005 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0526.xml 
035 |a (DE-627)NLM157631877 
035 |a (NLM)16146606 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Li, Xiao-yong  |e verfasserin  |4 aut 
245 1 0 |a Study on treatment strategy for ventriculitis associated with ventriculoperitoneal shunt for hydrocephalus 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 07.08.2009 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To study the treatment strategy for ventriculitis associated with ventriculo peritoneal shunt for hydrocephalus 
520 |a METHODS: For all of the patients suspected to have cerebrospinal fluid (CSF) infections, the first step of treatment was removal of the "infected" shunts, then a ventricular drainage was placed in frontal horn of the ventricle, and at the same time CSF was obtained from the ventricle for bacterial culture and tests of bacterial sensitivities to antibiotics. After the shunt removal and before the result from bacterial cultures was obtained, 25-50 mg of vancomycin was administered intraventricularly daily. As soon as the result from bacterial cultures was obtained, antibiotics should be adjusted according to the sensitivity test result. By the time of the infections being controlled, appropriate treatments including reshunting would finally be given for hydrocephalus if necessary 
520 |a RESULTS: Among 11 patients, 9 were infected with coagulase-negative Staphylococci or Staphylococcus epidermidis and Staphylococcus aureus, one of them with concomitant infection of aerobacter cloacae, Klebsiella pneumoniae and enterobacteriaceae aerogenesis, 1 patient with Streptococci, and another one with Mycobacterium stercoris bovis. The tests of drug sensitivity showed that cocci in infection of 9 patients were all sensitive to vancomycin, but only 1 of them sensitive to gentamycin. There were other sensitive antibiotics for streptococcus in 1 case and for bacillus in 2 patients. Practically vancomycin was effective for 8 of 11 patients, including one case of streptococcal infection. The duration for anti-infection treatment was in a range of 16-36 days. Finally, all of 11 patients survived from the shunt ventriculitis, and 9 of them had significant improvement in their neurological functions 
520 |a CONCLUSION: (1)Intraventricular administration of proper antibiotics is a reliable and effective way to treat ventriculitis associated with ventriculoperitoneal shunts. (2)Vancomycin is the preferred antibiotic for ventriculitis, but other kind(s) of some antibiotics are necessary in a few patients in addition to or instead of vancomycin. (3)The effect of systemic use of antibiotics could not be defined in this series of patients, but this may be used as an adjunct in the practice. (4)There are many problems related to diagnosis and treatment of shunt ventriculitis that should be studied more extensively and deeply 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Anti-Bacterial Agents  |2 NLM 
650 7 |a Vancomycin  |2 NLM 
650 7 |a 6Q205EH1VU  |2 NLM 
700 1 |a Wang, Zhong-cheng  |e verfasserin  |4 aut 
700 1 |a Li, Yin-Ping  |e verfasserin  |4 aut 
700 1 |a Ma, Zhen-yu  |e verfasserin  |4 aut 
700 1 |a Yang, Jun  |e verfasserin  |4 aut 
700 1 |a Cao, Er-cheng  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 17(2005), 9 vom: 08. Sept., Seite 558-60  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:17  |g year:2005  |g number:9  |g day:08  |g month:09  |g pages:558-60 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 17  |j 2005  |e 9  |b 08  |c 09  |h 558-60